Polymorphisms in the SLC2A2 (GLUT2) gene are associated with the conversion from impaired glucose tolerance to type 2 diabetes -: The Finnish Diabetes Prevention Study

被引:68
|
作者
Laukkanen, O
Lindström, J
Eriksson, J
Valle, TT
Hämäläinen, H
Ilanne-Parikka, P
Keinänen-Kiukaanniemi, S
Tuomilehto, J
Uusitupa, M
Laakso, M [1 ]
机构
[1] Univ Kuopio, Dept Med, SF-70210 Kuopio, Finland
[2] Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Diabet & Genet Epidemiol Unit, Helsinki, Finland
[3] Social Insurance Inst, Dept Res, Turku, Finland
[4] Tampere Univ Hosp, Finnish Diabet Assoc, Tampere, Finland
[5] Tampere Univ Hosp, Dept Internal Med, Tampere, Finland
[6] Oulu Univ, Oulu Univ Hosp, Dept Publ Hlth Sci & Gen Practice, Oulu, Finland
[7] Oulu Deaconess Inst, Dept Publ Hlth, Oulu, Finland
[8] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland
[9] Univ Kuopio, Dept Clin Nutr, FIN-70211 Kuopio, Finland
关键词
D O I
10.2337/diabetes.54.7.2256
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Impaired insulin secretion is a fundamental defect in type 2 diabetes. The aim of this study was to investigate whether single nucleotide polymorphisms (SNPs) in the genes regulating insulin secretion (SLC2A2 [encoding GLUT2], GCK, TCF1 [encoding HNF-1], HNF4A, GIP, and GLP1R) are associated with the conversion from impaired glucose tolerance (IGT) to type 2 diabetes in participants of the Finnish Diabetes Prevention Study. With the exception of SLC2A2, other genes were not associated with the risk of type 2 diabetes. All four SNPs of SLC2A2 predicted the conversion to diabetes, and rs5393 (AA genotype) increased the risk of type 2 diabetes in the entire study population by threefold (odds ratio 3.04, 95% Cl 1.34 - 6.88, P = 0.008). The risk for type 2 diabetes in the AA genotype carriers was increased in the control group (5.56 [1.78-17.391, P = 0.003) but not in the intervention group. We conclude that the SNPs of SLC2A2 predict the conversion to diabetes in obese subjects with IGT.
引用
下载
收藏
页码:2256 / 2260
页数:5
相关论文
共 50 条
  • [21] Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion
    J. Wang
    J. Kuusisto
    M. Vänttinen
    T. Kuulasmaa
    J. Lindström
    J. Tuomilehto
    M. Uusitupa
    M. Laakso
    Diabetologia, 2007, 50 : 1192 - 1200
  • [22] Insulin Secretion and Its Determinants in the Progression of Impaired Glucose Tolerance to Type 2 Diabetes in Impaired Glucose-Tolerant Individuals The Finnish Diabetes Prevention Study
    de Mello, Vanessa D. F.
    Lindstrom, Jaana
    Eriksson, Johan
    Ilanne-Parikka, Pirjo
    Keinanen-Kiukaanniemi, Sirkka
    Sundvall, Jouko
    Laakso, Markku
    Tuomilehto, Jaakko
    Uusitupa, Matti
    DIABETES CARE, 2012, 35 (02) : 211 - 217
  • [23] Physical activity modifies the effect of SNPs in the SLC2A2 (GLUT2) and ABCC8 (SUR1) genes on the risk of developing type 2 diabetes
    Kilpelaeinen, T. O.
    Lakka, T. A.
    Laaksonen, D. E.
    Laukkanen, O.
    Lindstroem, J.
    Eriksson, J. G.
    Valle, T. T.
    Haemaelaeinen, H.
    Aunola, S.
    Ilanne-Parikka, P.
    Keinaenen-Kiukaanniemi, S.
    Tuomilehto, J.
    Uusitupa, M.
    Laakso, M.
    PHYSIOLOGICAL GENOMICS, 2007, 31 (02) : 264 - 272
  • [24] Association of the Leu72Met polymorphism of the ghrelin gene with the risk of Type 2 diabetes in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study
    Mager, U.
    Lindi, V.
    Lindstrom, J.
    Eriksson, J. G.
    Valle, T. T.
    Hamalainen, H.
    Ilanne-Parikka, P.
    Keinanen-Kiukaanniemi, S.
    Tuomilehto, J.
    Laakso, M.
    Pulkkinen, L.
    Uusitupa, M.
    DIABETIC MEDICINE, 2006, 23 (06) : 685 - 689
  • [25] Genetic variation in uncoupling protein 2 gene is associated with type 2 diabetes in subjects with impaired glucose tolerance
    Salopuro, T
    Pulkkinen, L
    Lindström, J
    Tuomilehto, J
    Laakso, M
    Uusitupa, M
    INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 : S110 - S110
  • [26] A variant of the glucose transporter gene SLC2A2 modifies the glycaemic response to metformin therapy in recently diagnosed type 2 diabetes
    Rathmann, Wolfgang
    Strassburger, Klaus
    Bongaerts, Brenda
    Kuss, Oliver
    Muessig, Karsten
    Burkart, Volker
    Szendroedi, Julia
    Kotzka, Joerg
    Knebel, Birgit
    Al-Hasani, Hadi
    Roden, Michael
    DIABETOLOGIA, 2019, 62 (02) : 286 - 291
  • [27] High incidence of type 2 diabetes and increasing conversion rates from impaired fasting glucose and impaired glucose tolerance to diabetes in Mauritius
    Söderberg, S
    Zimmet, P
    Tuomilehto, J
    De Courten, M
    Dowse, GK
    Chitson, P
    Stenlund, H
    Gareeboo, H
    Alberti, KGMM
    Shaw, J
    JOURNAL OF INTERNAL MEDICINE, 2004, 256 (01) : 37 - 47
  • [28] A variant of the glucose transporter gene SLC2A2 modifies the glycaemic response to metformin therapy in recently diagnosed type 2 diabetes
    Wolfgang Rathmann
    Klaus Strassburger
    Brenda Bongaerts
    Oliver Kuss
    Karsten Müssig
    Volker Burkart
    Julia Szendroedi
    Jörg Kotzka
    Birgit Knebel
    Hadi Al-Hasani
    Michael Roden
    Diabetologia, 2019, 62 : 286 - 291
  • [29] Evidence for a Genotype-Phenotype Correlation in Patients with Pathogenic GLUT2 (SLC2A2) Variants
    Gruenert, Sarah C.
    Schumann, Anke
    Baronio, Federico
    Tsiakas, Konstantinos
    Murko, Simona
    Spiekerkoetter, Ute
    Santer, Rene
    GENES, 2021, 12 (11)
  • [30] MafA, NeuroD1 and HNF1β synergistically activate the Slc2a2 (Glut2) gene in β-cells
    Ono, Yuka
    Kataoka, Kohsuke
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2021, 67 (03) : 71 - 82